|
|
||||||||
RAPID COMMUNICATION |
a Geron Corporation, Menlo Park, California, USA and
b The Terry Fox Laboratory, Vancouver, British Columbia, Canada
Key Words. Telomerase • Hematopoietic progenitors • TRAP assay • Primitive stem cells • Human bone marrow
Dr. Choy-Pik Chiu, Geron Corporation, 200 Constitution Drive, Menlo Park, CA 94025, USA or Dr. Peter Lansdorp, Terry Fox Laboratory, British Columbia Cancer Research Centre, 601 West 10th Avenue, Vancouver, B.C., Canada, V5Z 1L3.
The loss of telomeric DNA may serve as a mitotic clock which signals cell senescence and exit from cell cycle. Telomerase, an enzyme which synthesizes telomeric repeats de novo, is required to maintain telomere lengths. In humans, significant telomerase activity has been found in cells with essentially unlimited replicative potential such as reproductive cells in ovaries and testes, immortal cell lines and cancer tissues, but not in most normal somatic cells or tissues. We have now examined telomerase expression in subpopulations of hematopoietic cells from adult human bone marrow using a sensitive polymerase chain reaction-based telomeric repeat amplification protocol. Telomerase activity was found at low levels in the highly enriched primitive hematopoietic cells (CD34+CD71loCD45RAlo) and was increased transiently when these cells were cultured in the presence of a mixture of cytokines. In contrast, the early progenitors (CD34+CD71+) expressed telomerase activity at a higher level which was subsequently downregulated in response to cytokines. Telomerase activity remained low in the more mature CD34 cells upon exposure to cytokines. Taken together, our results suggest that telomerase is expressed at a basal level in all hematopoietic cell populations examined, is induced in a primitive subset of hematopoietic progenitor cells and is downregulated upon further proliferation and differentiation of these cells. We have previously observed telomere shortening in cytokine-stimulated primitive hematopoietic cells. The low and transient activation of telomerase activity described here thus appears insufficient to maintain telomere lengths in cultured hematopoietic cells.
This article has been cited by other articles:
![]() |
S. R. Narala, R. C. Allsopp, T. B. Wells, G. Zhang, P. Prasad, M. J. Coussens, D. J. Rossi, I. L. Weissman, and H. Vaziri SIRT1 Acts as a Nutrient-sensitive Growth Suppressor and Its Loss Is Associated with Increased AMPK and Telomerase Activity Mol. Biol. Cell, March 1, 2008; 19(3): 1210 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Milanovic, P. Maier, F. Wenz, and C. Herskind Changes in telomerase activity after irradiation of human peripheral blood mononuclear cells (PBMC) in vitro Radiat Prot Dosimetry, December 1, 2006; 122(1-4): 173 - 175. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Miyoshi, S. Hirohata, H. Ogawa, M. Doi, M. Obika, T. Yonezawa, Y. Sado, S. Kusachi, S. Kyo, S. Kondo, et al. Tumor-specific expression of the RGD-{alpha}3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice FASEB J, September 1, 2006; 20(11): 1904 - 1906. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jaras, A. Edqvist, J. Rebetz, L. G. Salford, B. Widegren, and X. Fan Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression Blood, August 1, 2006; 108(3): 1084 - 1091. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Umemoto, M. Yamato, K. Nishida, J. Yang, Y. Tano, and T. Okano Limbal Epithelial Side-Population Cells Have Stem Cell-Like Properties, Including Quiescent State Stem Cells, January 1, 2006; 24(1): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Y. Wang, J. K. Warner, N. Erdmann, P. M. Lansdorp, L. Harrington, and J. E. Dick Dissociation of telomerase activity and telomere length maintenance in primitive human hematopoietic cells PNAS, October 4, 2005; 102(40): 14398 - 14403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bartolovic, S. Balabanov, B. Berner, H.-J. Buhring, M. Komor, S. Becker, D. Hoelzer, L. Kanz, W.-K. Hofmann, and T. H. Brummendorf Clonal Heterogeneity in Growth Kinetics of CD34+CD38- Human Cord Blood Cells In Vitro Is Correlated with Gene Expression Pattern and Telomere Length Stem Cells, August 1, 2005; 23(7): 946 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Gardner, S. Li, S. R. Srinivasan, W. Chen, M. Kimura, X. Lu, G. S. Berenson, and A. Aviv Rise in Insulin Resistance Is Associated With Escalated Telomere Attrition Circulation, May 3, 2005; 111(17): 2171 - 2177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. PARDAL, A.V. MOLOFSKY, S. HE, and S.J. MORRISON Stem Cell Self-Renewal and Cancer Cell Proliferation Are Regulated by Common Networks That Balance the Activation of Proto-oncogenes and Tumor Suppressors Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 177 - 185. [Abstract] [PDF] |
||||
![]() |
S. Wang and J. Zhu The hTERT Gene Is Embedded in a Nuclease-resistant Chromatin Domain J. Biol. Chem., December 31, 2004; 279(53): 55401 - 55410. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zimmermann, S. Glaser, R. Ketteler, C. F. Waller, U. Klingmuller, and U. M. Martens Effects of Telomerase Modulation in Human Hematopoietic Progenitor Cells Stem Cells, September 1, 2004; 22(5): 741 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takeda, H. Inaba, M. Yamazaki, S. Kyo, T. Miyamoto, S. Suzuki, T. Ehara, T. Kakizawa, M. Hara, L. J. DeGroot, et al. Tumor-Specific Gene Therapy for Undifferentiated Thyroid Carcinoma Utilizing the Telomerase Reverse Transcriptase Promoter J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3531 - 3538. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Allsopp, G. B. Morin, R. DePinho, C. B. Harley, and I. L. Weissman Telomerase is required to slow telomere shortening and extend replicative lifespan of HSCs during serial transplantation Blood, July 15, 2003; 102(2): 517 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Roelofs, E. S. D. de Pauw, A. H. Zwinderman, S. M. Opdam, R. Willemze, H. J. Tanke, and W. E. Fibbe Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation Blood, January 1, 2003; 101(1): 358 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cui, S. Aslam, J. Fletcher, D. Wylie, M. Clinton, and A. J. Clark Stabilization of Telomere Length and Karyotypic Stability Are Directly Correlated with the Level of hTERT Gene Expression in Primary Fibroblasts J. Biol. Chem., October 4, 2002; 277(41): 38531 - 38539. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Samper, P. Fernandez, R. Eguia, L. Martin-Rivera, A. Bernad, M. A. Blasco, and M. Aracil Long-term repopulating ability of telomerase-deficient murine hematopoietic stem cells Blood, April 15, 2002; 99(8): 2767 - 2775. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.-p. Weng Interplay between telomere length and telomerase in human leukocyte differentiation and aging J. Leukoc. Biol., December 1, 2001; 70(6): 861 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Korbling and P. Anderlini Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter? Blood, November 15, 2001; 98(10): 2900 - 2908. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Wright, E. L. Jones, J. F. Mayer, S. Oehninger, W. E. Gibbons, and S. E. Lanzendorf Characterization of telomerase activity in the human oocyte and preimplantation embryo Mol. Hum. Reprod., October 1, 2001; 7(10): 947 - 955. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Komata, Y. Kondo, T. Kanzawa, S. Hirohata, S. Koga, H. Sumiyoshi, S. M. Srinivasula, B. P. Barna, I. M. Germano, M. Takakura, et al. Treatment of Malignant Glioma Cells with the Transfer of Constitutively Active Caspase-6 Using the Human Telomerase Catalytic Subunit (Human Telomerase Reverse Transcriptase) Gene Promoter Cancer Res., August 1, 2001; 61(15): 5796 - 5802. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chaves-Dias, T. R. Hundley, A. M. Gilfillan, A. S. Kirshenbaum, J. R. Cunha-Melo, D. D. Metcalfe, and M. A. Beaven Induction of Telomerase Activity During Development of Human Mast Cells from Peripheral Blood CD34+ Cells: Comparisons with Tumor Mast-Cell Lines J. Immunol., June 1, 2001; 166(11): 6647 - 6656. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Liu, R. J. Hodes, and N.-p. Weng Cutting Edge: Telomerase Activation in Human T Lymphocytes Does Not Require Increase in Telomerase Reverse Transcriptase (hTERT) Protein But Is Associated with hTERT Phosphorylation and Nuclear Translocation J. Immunol., April 15, 2001; 166(8): 4826 - 4830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bennaceur-Griscelli, C. Pondarre, V. Schiavon, W. Vainchenker, and L. Coulombel Stromal cells retard the differentiation of CD34+CD38low/neg human primitive progenitors exposed to cytokines independent of their mitotic history Blood, January 15, 2001; 97(2): 435 - 441. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Gu, S. Kagawa, M. Takakura, S. Kyo, M. Inoue, J. A. Roth, and B. Fang Tumor-specific Transgene Expression from the Human Telomerase Reverse Transcriptase Promoter Enables Targeting of the Therapeutic Effects of the Bax Gene to Cancers Cancer Res., October 1, 2000; 60(19): 5359 - 5364. [Abstract] [Full Text] |
||||
![]() |
T. H. Brummendorf, T. L. Holyoake, N. Rufer, M. J. Barnett, M. Schulzer, C. J. Eaves, A. C. Eaves, and P. M. Lansdorp Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry Blood, March 15, 2000; 95(6): 1883 - 1890. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Funakoshi, H. Nakayama, K. Uetsuka, R. Nishimura, N. Sasaki, and K. Doi Cellular Proliferative and Telomerase Activity in Canine Mammary Gland Tumors Vet. Pathol., March 1, 2000; 37(2): 177 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Rha, E. Izbicka, R. Lawrence, K. Davidson, D. Sun, M. P. Moyer, G. D. Roodman, L. Hurley, and D. Von Hoff Effect of Telomere and Telomerase Interactive Agents on Human Tumor and Normal Cell Lines Clin. Cancer Res., March 1, 2000; 6(3): 987 - 993. [Abstract] [Full Text] |
||||
![]() |
B. Heine, S. E Coupland, S. Kneiff, G. Demel, N. Bornfeld, M. Hummel, and H. Stein Telomerase expression in uveal melanoma Br. J. Ophthalmol., February 1, 2000; 84(2): 217 - 223. [Abstract] [Full Text] |
||||
![]() |
J. S. Dome, S. Chung, T. Bergemann, C. B. Umbricht, M. Saji, L. A. Carey, P. E. Grundy, E. J. Perlman, N. E. Breslow, and S. Sukumar High Telomerase Reverse Transcriptase (hTERT) Messenger RNA Level Correlates with Tumor Recurrence in Patients with Favorable Histology Wilms' Tumor Cancer Res., September 1, 1999; 59(17): 4301 - 4307. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Lavranos, J. M. Mathis, S. E. Latham, B. Kalionis, J. W. Shay, and R. J. Rodgers Evidence for Ovarian Granulosa Stem Cells: Telomerase Activity and Localization of the Telomerase Ribonucleic Acid Component in Bovine Ovarian Follicles Biol Reprod, August 1, 1999; 61(2): 358 - 366. [Abstract] [Full Text] |
||||
![]() |
N. Rufer, T. H. Brummendorf, S. Kolvraa, C. Bischoff, K. Christensen, L. Wadsworth, M. Schulzer, and P. M. Lansdorp Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood J. Exp. Med., July 19, 1999; 190(2): 157 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Hande, E. Samper, P. Lansdorp, and M. A. Blasco Telomere Length Dynamics and Chromosomal Instability in Cells Derived from Telomerase Null Mice J. Cell Biol., February 22, 1999; 144(4): 589 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. F. HALLORAN, A. MELK, and C. BARTH Rethinking Chronic Allograft Nephropathy: The Concept of AcceleratedSenescence J. Am. Soc. Nephrol., January 1, 1999; 10(1): 167 - 181. [Full Text] |
||||
![]() |
S. Kondo, Y. Tanaka, Y. Kondo, M. Hitomi, G. H. Barnett, Y. Ishizaka, J. Liu, T. Haqqi, A. Nishiyama, B. Villeponteau, et al. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation FASEB J, July 1, 1998; 12(10): 801 - 811. [Abstract] [Full Text] |
||||
![]() |
M. Fossel Telomerase and the Aging Cell: Implications for Human Health JAMA, June 3, 1998; 279(21): 1732 - 1735. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Ball, F. M. Gibson, S. Rizzo, J. A. Tooze, J. C.W. Marsh, and E. C. Gordon-Smith Progressive Telomere Shortening in Aplastic Anemia Blood, May 15, 1998; 91(10): 3582 - 3592. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Frenck Jr., E. H. Blackburn, and K. M. Shannon The rate of telomere sequence loss in human leukocytes varies with age PNAS, May 12, 1998; 95(10): 5607 - 5610. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yui, C.-P. Chiu, and P. M. Lansdorp Telomerase Activity in Candidate Stem Cells From Fetal Liver and Adult Bone Marrow Blood, May 1, 1998; 91(9): 3255 - 3262. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Bodnar, M. Ouellette, M. Frolkis, S. E. Holt, C. Chiu, G. B. Morin, C. B. Harley, J. W. Shay, S. Lichtsteiner, and W. E. Wright Extension of Life-Span by Introduction of Telomerase into Normal Human Cells Science, January 16, 1998; 279(5349): 349 - 352. [Abstract] [Full Text] |
||||
![]() |
R. Notaro, A. Cimmino, D. Tabarini, B. Rotoli, and L. Luzzatto In vivo telomere dynamics of human hematopoietic stem cells PNAS, December 9, 1997; 94(25): 13782 - 13785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Stampfer, A. Bodnar, J. Garbe, M. Wong, A. Pan, B. Villeponteau, and P. Yaswen Gradual Phenotypic Conversion Associated with Immortalization of Cultured Human Mammary Epithelial Cells Mol. Biol. Cell, December 1, 1997; 8(12): 2391 - 2405. [Abstract] [Full Text] |
||||
![]() |
N.-p. Weng, L. Granger, and R. J. Hodes Telomere lengthening and telomerase activation during human B cell differentiation PNAS, September 30, 1997; 94(20): 10827 - 10832. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Engelhardt, R. Kumar, J. Albanell, R. Pettengell, W. Han, and M. A.S. Moore Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells Blood, July 1, 1997; 90(1): 182 - 193. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
